//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Updated review 2026 style- Hallmarks of cancer: then, now and beyond by D Hanahan www.cell.com/cell/fulltex...
Ok, let's define "science" thehill.com/policy/healt...
Projected Cancer Screening and Outcomes Under the 2025 Federal Medicaid Eligibility Restrictions: jamanetwork.com/journals/jam...
Link here to the War Powers Resolution Reporting Project, at NYU. 4/4 - warpowers.lawandsecurity.org?fbclid=IwdGR...
We can do better #genomics #globalhealth #precisionmedicine Human genomics technologies in clinical studies – the research landscape: report on the 1990-2024 period www.who.int/publications...
Now we are talking: #raredisease model from a population perspective #precisionmedicine with Proteomic stability and localization (maybe still early but progress from that good stuff brought to pharma 😊 long ago) www.nature.com/articles/s41...
Conversational interoperability in agentic interactions, a maze-ing paradigm to benchmark: arxiv.org/abs/2511.02687
LLM ChatGPT-n models built on models? No shocker: Primary data of quality and review (#dataequity) needs to be used for insights www.nature.com/articles/s41...
Love the effort to integrate genetic data into Dx needs of the patient. Great for #raredisease but shouldn't this be knowledge generation be used for all conditions (since cost of a genome has been reduced) #precisionmedicine www.forbes.com/sites/jaimec...?
MisDx in common diseases can be reduced with genomic testing #precisionmedicine (and find #raredisease) #NGS www.nejm.org/doi/full/10....
4mo
4mo
5mo
5mo
6mo
6mo
7mo
7mo
8mo
8mo
thehill.com
This decision analytical model evaluates projected changes in cancer screening and outcomes following changes to federal Medicaid funding and eligibility restrictions enacted with the 2025 Budget Reco...
Projected Cancer Screening Under the 2025 Medicaid Eligibility Restrictions
jamanetwork.com
A living resource on presidential reporting practice and the use of U.S. armed forces abroad.
warpowers.lawandsecurity.org
This snapshot provides a global overview of clinical studies involving human genomic technologies that were registered between 1990 and 2024.
www.who.int
War Powers Resolution Reporting Project
Human genomics technologies in clinical studies – the research landscape: report on the 1990-2024 period
Proteome-wide model for human disease genetics - Nature Genetics
popEVE is a proteome-wide deep generative model to identify and predict pathogenicity of missense mutations causing genetic disorders.
www.nature.com
The trajectory of AI development suggests that we will increasingly rely on agent-based systems composed of independently developed agents with different information, privileges, and tools. The succes...
arxiv.org
The Collaboration Gap
 Analysis shows that indiscriminately training generative artificial intelligence on real and generated content, usually done by scraping data from the Internet, can lead to a collapse in th...
www.nature.com
Hanahan revisits the evolving framework of cancer hallmarks, synthesizing 25 years of conceptual refinement into a multidimensional view of tumor biology. This review highlights how aberrant capabilit...
www.cell.com
AI models collapse when trained on recursively generated data - Nature
Hallmarks of cancer—Then and now, and beyond
AI is powering a new era of “one-patient medicine,” cutting drug costs and creating personalized cures that could transform healthcare and finance.
www.forbes.com
Misdiagnosis or underdiagnosis of rare diseases in patients with diagnoses of common diseases can lead to delayed or inappropriate treatments, thereby complicating the management of both rare and c...
www.nejm.org
The ROI Of AI Medicine—Where Custom Cures Meet Smart Money
Common Diseases in Clinical Cohorts — Not Always What They Seem | NEJM
Brett Johnson
Brett Johnson
Brett Johnson
Brett Johnson
Brett Johnson
Brett Johnson
Steven Seegel
Brett Johnson
Brett Johnson
Brett Johnson